<DOC>
	<DOCNO>NCT02270983</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy linaclotide treatment opioid-induced constipation ( OIC ) , adult receive stable opioid treatment chronic non-cancer pain present minimum 3 month . This study include 4-week Screening Period , 2 3-week Pretreatment Period . Patients meet entry criterion randomize 1 2 dos linaclotide placebo 8 week . This 8-week study ass effect linaclotide bowel movement frequency , well bowel symptom OIC .</brief_summary>
	<brief_title>Phase 2 Randomized , Double-Blind , Placebo-Controlled , Parallel Group Trial Linaclotide Administered Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment Non-Cancer Pain</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Patient chronic noncancer pain present minimum 3 month Patient receive stable dose fullopioid agonist least 4 day per week 8 consecutive week Patient meet protocol criterion OpioidInduced Constipation ( OIC ) : &lt; 3 spontaneous bowel movement ( SBMs ) per week report one follow symptom least 4 week : 1 . Straining &gt; 25 % BMs 2 . Lumpy hard stool &gt; 25 % BMs 3 . Sensation incomplete evacuation &gt; 25 % BMs Patient meet colonoscopy requirement define American Gastroenterological Association guideline Patient successfully complete protocol procedure ( clinically significant finding ) Patient compliant Interactive Voice Response System ( IVRS ) daily diary reporting Patient total &lt; 6 SBMs IVRS 14 day time Randomization Patient adequate relief wellcontrolled pain current dose opioid Patient use opioids abdominal pain Patient symptom diagnose chronic constipation chronic idiopathic constipation prior initiation opioid treatment Patient symptom diagnose Irritable Bowel Syndrome ( IBS ) prior initiation opioid treatment Patient history loose watery stool &gt; 25 % BMs 3 month Screening absence laxative , suppository , enema Patient structural abnormality gastrointestinal ( GI ) tract disease condition affect GI motility Patient protocolexcluded clinically significant medical surgical history would limit patient 's ability complete participate clinical trial could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Opioid-Induced Constipation</keyword>
	<keyword>Linaclotide</keyword>
	<keyword>Linzess</keyword>
</DOC>